TScan Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRX and other ETFs, options, and stocks.

About TCRX

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. 

CEO
Gavin MacBeath
CEOGavin MacBeath
Employees
154
Employees154
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2018
Founded2018
Employees
154
Employees154

TCRX Key Statistics

Market cap
298.85M
Market cap298.85M
Price-Earnings ratio
-3.61
Price-Earnings ratio-3.61
Dividend yield
—
Dividend yield—
Average volume
298.59K
Average volume298.59K
High today
$7.13
High today$7.13
Low today
$6.71
Low today$6.71
Open price
$6.82
Open price$6.82
Volume
278.82K
Volume278.82K
52 Week high
$9.00
52 Week high$9.00
52 Week low
$1.62
52 Week low$1.62
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.